Temporary anti-CD25/CsA therapy induces a CD4+ T-cell-mediated tolerance in BB/OK rats

Journal of Autoimmunity

Volumn 9, Issue 3, 1996, Pages 321-329

  Kuttler, Beate ^a   Kauert, Christiane ^b   Wanka, Heike ^b   Diamantstein, Tibor ^b   Hahn, Hans Jürgen ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b NONE

Author keywords

Anti CD25 therapy; BB rat; Islet transplantation; T(H2) like cells; Tolerance induction

Indexed keywords

CD4 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 0030175323     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0044     Document Type: Conference Paper

References (43)

1. 1. Lafferty K.J., Ronald G., Babcock S. 1986. Tolerance induction in adult animals - the Ciclosporin anomaly. In Ciclosporin. Progress in Allergy, Vol. 38. J.F. Borel, ed. Karger, Basel, pp. 247-257
2. 2. Witherspoon J.S., Dorsch, S.E. 1989. Graft-versus-host resistance induced by tolerant cell populations. Evidence against clonal deletion as a mechanism of transplantation tolerance. Transplantation 47: 528-532
3. 3. Lafferty, K.J. 1994. A contemporary view of transplantation tolerance: an immunologist's perspective. Clin. Transplant. 8: 181-187
4. 4. Saitovich D., Bushell A.R., Morris P.J., Wood K.J. 1995. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period is required for the development of immunological unresponsiveness. Transplant. Proc. 27: 117-118
5. 5. Olausson M., Mjörnstedt L., Wrammer L., Söderström T.T., Brynger H. 1987. Importance of the presence of antigen for induction of transplantation tolerance. Transplant. Proc. 19: 454-456
6. 6. Scully R., Qin S., Cobbold S., Waldmann H. 1994. Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory cells. Eur. J. Immunol. 24: 2383-2392
7. 7. Arnold B., Schönrich G., Hämmerling G.J. 1993. Multiple levels of peripheral tolerance. Immunol. Today 14: 12-14
8. 8. Gotoh M., Porter J., Monaco A.P., Maki T. 1988. Induction of antigen-specific unresponsiveness to pancreatic islet allografts by antilymphocyte serum. Transplantation 45: 429-433
9. 9. Tsugita M., Tsuru S., Taniguchi M., Shinomiya N., Ikeda M. 1989. Cholera toxin induced tolerance to murine allografts. Transplant. Proc. 21: 276-277
10. 10. Cuturi M.C., Josien R., Cantarovich D., Bugeon L., Angeon I., Menoret S., Smit H., Douillard P., Soulillou J.P. 1994. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats. Eur. J. Immunol. 24: 1627-1631
11. 11. Waer M., Palathumpat V., Sobis H., Vandeputte M. 1990. Induction of transplantation tolerance in mice across major histocompatibility barrier by using allogeneic thymus transplantation and total lymphoid irradiation. Transplantation 145: 499-504
12. 12. Madsen J.C., Superina R.A., Wood K.J., Morris P.J. 1988. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 332: 161-164
13. 13. Remuzzi G., Perico N., Carpenter C.B., Sayegh M.H. 1995. The thymic way to transplantation tolerance. J. Am. Soc. Nephrol. 5: 1639-1646
14. 14. Waldmann H., Cobbold S., Qin S., Leong L. 1992. Transplantation tolerance with monoclonal antibodies. In A Critical Analysis of Monoclonal Antibody Therapy in Transplantation. W.J. Burlingham, ed. CRC Press, Boca Raton, Ann Arbor and London, pp. 67-78
15. 15. Pearson T.C., Alexander D.Z., Winn K.J., Linsley P.S., Lowry R.P., Larson C.P. 1994. Transplantation tolerance induced by CTLA4-Ig. Transplantation 57: 1701-1706
16. 16. Alters S.E., Grossman D., Fathman C.G. 1992. Anti-CD4-mediated transplantation tolerance: mechanisms and memory. In A Critical Analysis of Monoclonal Antibody Therapy in Transplantation. W.J. Burlingham, ed. CRC Press, Boca Raton, Ann Arbor and London, pp. 79-99
17. 17. Hirsch R., Gress R.E., Bluestone J.A. 1992. Anti-CD3-mediated immunotherapy: a murine model. In A Critical Analysis of Monoclonal Antibody Therapy in Transplantation. W.J. Burlingham, ed. CRC Press, Boca Raton, Ann Arbor and London, pp. 1-15
18. 18. Soulillou J.P., Cantarovich D., Dantal J., Hourmant M., LeMauff B., Jaques Y. 1992. Anti-IL-2 receptor and anti-LFA-1 monoclonal antibodies in transplantation: Rational and Nantes clinical experience. In A Critical Analysis of Monoclonal Antibody Therapy in Transplantation. W.J. Burlingham, ed. CRC Press, Boca Raton, Ann Arbor and London, pp. 47-66
19. 19. Hahn H.J., Kuttler B., Dunger A., Lucke S., Volk H.D., Diamantstein T. 1991. Temporary anti-CD25 treatment results in tolerance development in syngeically grafted autoimmune diabetic recipients. Transplant. Proc. 23: 741-742
20. 20. Diamantstein T., Hahn H.J. 1993. Interleukin-2 receptor-targeted immune therapy. In Monoclonal Antibodies and Peptide Therapy in Autoimmune Diseases. J.F. Bach, ed. Marcel Dekker Inc., New York, pp. 295-318
21. 21. Kuttler B., Lucke S., Vogt L., Klöting I., Diamantstein T., Hahn H.J. 1996. Immunotherapy of insulin-dependent diabetes mellitus: Tolerance after short-term anti-IL-2 receptor/Cyclosporine therapy in BB/OK rats. In Lessons from Animal Diabetes, Vol. 6. E. Shafrir, ed. Smith-Gordon & Co. Ltd, in press
22. 22. Chatenoud L., Primo J., Bach J.F. 1995. Monoclonal antibodies to CD3 restore self tolerance in overtly diabetic NOD mice: Both mitogenic and non-mitogenic antibodies afford tolerance. Autoimmunity 21: 72 (A276)
23. 23. Hahn H.J., Kuttler B., Klöting I., Dunger A., Besch W., Diamantstein T. 1992. Extended survival of MHC-identical allogeneic islet grafts in diabetic BB rats - effect of an IL-2 receptor targeted immunotherapy. Transplantation 54: 555-558
24. 24. Klöting I., Reiher K. 1985. Einige Aspekte zur Haltung und Reproduktion spontandiabetischer BB Ratten. Z. Versuchstierk. 27: 5-11
25. 25. Klöting I., Vogt L., Günther E., Wurst W., Hedrich H.J., Reetz I.C. 1989. Availability of newly established congenic rat strains LEW.1BB and BB.1A. Rat News Lett. 21: 22-23
26. 26. Hehmke B., Kohnert K.D., Odselius P. 1986. The use of a new dextran gradient for rapid isolation of functionally intact neonatal pancreatic islets. Diabetes Res. 3: 13-16
27. 27. Hahn H.J. 1978. Die isolierte Langerhanssche Insel, ein Modell zur Untersuchung der Insulinsekretion in vitro. Endokrinologie 71: 308-324
28. 28. Kuttler B., Volk H.D., Kauert C., Diamantstein T., Hahn H.J. 1990. Phenotyping of lymphocytes following transplantation of allogeneic rat pancreatic islets into streptozotocin-diabetic recipients. Exp. Clin. Endocrinol. 95: 64-69
29. 29. Gowans J.L., Knight E.J. 1964. The role of re-circulation of lymphocytes in the rat. Proc. R. Soc. Lond. B. Biol. Sci. 159: 257-263
30. 30. Kuttler B., Lehmann M., Lacha J., Brock J., Hahn H.J. 1994. Anti-CD4 therapy induces a donor-specific, organ-unspecific tolerance in allogeneic kidney graft recipients. Transplant. Proc. 26: 728-729
31. + T cells defined by their expression of different isoforms of the leucocyte-common antigen, CD45. Biochem Soc. Transactions 20: 188-190
32. 32. Hahn H.J., Kauert C., Dunger A., Kuttler B., Diamantstein T. 1989. Interleukin-2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK rats grafted with BB/OK rat islets. Autoimmunity 5: 139-142
33. 33. Charlton B., Auchincloss Jr. H., Fathman C.G. 1994. Mechanisms of transplantation tolerance. Ann. Rev. Immunol. 12: 707-734
34. + T cells defined by their differential expression of variants of the CD45 antigen: developmental relationships and in vitro and in vivo functions. Curr. Top. Microbiol. Immunol. 159: 79-85
35. + phenotype. J. Exp. Med. 169: 653-660
36. 36. McKnight A.J., Barclay A.N., Mason D.W. 1990. Analysis of the lymphokine repertoire of rat T cell subpopulations. In Cytokines: Basic Principles and Clinical Applications. S. Romagnani, A.K. Abbas, eds. Raven Press Ltd, New York, pp. 151-155
37. + T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123: 37-64
38. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177: 627-636
39. 39. De Carli M., D'Elios M.M., Zancuoghi G., Romagnani S., Del Prete G. 1994. Human TH1 and TH2 cells: Functional properties, regulation of development and role in autoimmunity. Autoimmunity 18: 301-308
40. + subset. Cell Immunol. 114: 336-346
41. 41. Greiner D.L., Handler E.S., Nakano K., Mordes J.P., Rossini A.A. 1986. Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J. Immunol. 136: 148-151
42. 42. Rossini A.A., Mordes J.P., Greiner D.L., Nakano K., Appel M.C., Handler E.S. 1986. Spleen cell transfusion in the BB/W rat: Prevention of diabetes, MHC restriction, and long term persistence of transfused cells. J. Clin. Invest. 77: 1399-1401
43. + T lymphocytes induces diabetes in resistant BioBreeding/Worcester (BB/W) rats. J. Exp. Med. 166: 461-475